Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 995, pseudogene (RNU6-995P) is a **pseudogene** of the U6 small nuclear RNA (U6 snRNA) family[4]. U6 snRNA itself is a fundamental component of the spliceosome, essential for the removal of introns from pre-mRNA in eukaryotic cells[1][3]. However, RNU6-995P is annotated as a pseudogene, meaning it is a non-functional, typically non-coding copy derived from the functional U6 gene[4]. Pseudogenes generally do not code for functional products but may exert regulatory roles at the RNA level, such as acting as decoys for miRNAs, antisense RNAs, or regulators of parental genes[2]. There is no evidence suggesting RNU6-995P itself functions as a therapeutic target, nor is it documented as functionally expressed or associated with any disease or therapeutic mechanism. Its nomenclature, function, and classification are strictly as a pseudogene, not as a receptor, enzyme, or direct cellular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 995, pseudogene (RNU6-995P).